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Abstract
It has been reported that surface microstructural dimensions 
can influence the osteoinductivity of calcium phosphates 
(CaPs), and osteoclasts may play a role in this process. We 
hypothesised that surface structural dimensions of ≤ 1 μm 
trigger osteoinduction and osteoclast formation irrespective 
of macrostructure (e.g., concavities, interconnected 
macropores, interparticle space) or surface chemistry. To 
test this, planar discs made of biphasic calcium phosphate 
(BCP: 80 % hydroxyapatite, 20 % tricalcium phosphate) 
were prepared with different surface structural dimensions 
– either ~ 1 μm (BCP1150) or ~ 2-4 μm (BCP1300) 
– and no macropores or concavities. A third material 
was made by sputter coating BCP1150 with titanium 
(BCP1150Ti), thereby changing its surface chemistry but 
preserving its surface structure and chemical reactivity. 
After intramuscular implantation in 5 dogs for 12 weeks, 
BCP1150 formed ectopic bone in 4 out of 5 samples, 
BCP1150Ti formed ectopic bone in 3 out of 5 samples, and 
BCP1300 formed no ectopic bone in any of the 5 samples. 
In vivo, large multinucleated osteoclast-like cells densely 
colonised BCP1150, smaller osteoclast-like cells formed 
on BCP1150Ti, and osteoclast-like cells scarcely formed 
on BCP1300. In vitro, RAW264.7 cells cultured on the 
surface of BCP1150 and BCP1150Ti in the presence of 
osteoclast differentiation factor RANKL (receptor activator 
for NF-κB ligand) proliferated then differentiated into 
multinucleated osteoclast-like cells with positive tartrate 
resistant acid phosphatase (TRAP) activity. However, 
cell proliferation, fusion, and TRAP activity were all 
significantly inhibited on BCP1300. These results indicate 
that of the material parameters tested – namely, surface 
microstructure, macrostructure, and surface chemistry 
– microstructural dimensions are critical in promoting 
osteoclastogenesis and triggering ectopic bone formation.
Keywords: Biphasic calcium phosphate, topography, 
microstructure, osteoclast, osteoinduction.
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Introduction
Certain calcium phosphates (CaPs) can induce de novo 
bone formation without exogenous stem cells or growth 
factors, making them particularly attractive for use as 
bone graft substitutes (Ripamonti, 1991; Yuan et al., 
2010). Although the material parameters and biological 
signalling necessary to induce de novo bone formation 
are unclear, osteoinductive CaPs developed by different 
groups seem to share similar surface structure, specifically 
surface topographical features on a (sub)micron-scale. For 
instance, hydroxyapatite (HA) with surface micrograins 
and micropores induced ectopic bone formation in dogs 
and goats, but HA with a denser surface of large, fused 
grains and few micropores did not (Habibovic et al., 
2005b; Yamasaki and Sakai, 1992; Yuan et al., 1998; 
Yuan et al., 1999). Similarly, microstructured biphasic 
calcium phosphate (BCP) – a mixture of HA and tricalcium 
phosphate (TCP) – induced de novo bone formation in 
the muscle of sheep (Le Nihouannen et al., 2005), goats 
(Habibovic et al., 2005b; Yuan et al., 2002), and dogs 
(Yuan et al., 2010); however, BCP with larger grains and 
fewer micropores induced less bone formation (Yuan et al., 
2010) or in other cases none at all (Habibovic et al., 2006b). 
More recently, the dimensions of surface microstructure 
have also been shown to be important for osteoinduction 
– for instance, TCP with submicron-scale surface structure 
consistently stimulated de novo bone formation in dog 
muscle, while TCP with micron-scale surface structure 
was not at all osteoinductive (Davison et al., 2014b; Zhang 
et al., 2014). Surface microstructure may also be critical 
in triggering osteoinduction by other biomaterials such as 
titanium (Fujibayashi et al., 2004; Fukuda et al., 2011).
 Macroscale features of osteoinductive biomaterials 
such as interconnected macropores, particle size, and 
surface concavities have also been previously speculated to 
be “essential” and “requisite” for de novo bone formation 
(Habibovic et al., 2005a; Habibovic et al., 2005b; Magan 
and Ripamonti, 1996; Yuan et al., 2002). However, 
extensive de novo bone can also form in the intramuscular 
space between non-macroporous, microporous CaP 
particles (Yuan and de Bruijn, 2011). Thus, it is still unclear 
if interparticle space along with microstructure is necessary 
for osteoinduction or if de novo bone can also form on a 
macroscopically flat surface.
 The physicochemical properties of CaPs are also 
theorised to be crucial for osteoinduction through the 
formation of a crystalline carbonate apatite surface layer 
after implantation (Daculsi et al., 1989; LeGeros, 2008). 
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The solubility of a given CaP (e.g., the HA/TCP ratio 
in the case of BCP), as well as its microstructure (e.g., 
surface micropore and crystal grain size) contribute to this 
mineralised surface layer by modulating the dissolution/
reprecipitation of calcium and phosphate ions in body 
fluid (Daculsi et al., 1990). The biological relevance of 
surface reactivity and a precipitated layer of carbonate 
apatite is speculated to be either a direct physicochemical 
trigger for osteogenesis (i.e., the differentiation of bone 
forming osteoblasts from uncommitted precursors) through 
elevated local calcium and phosphate levels (Barradas et 
al., 2013; Beck et al., 2000; Syed-Picard et al., 2013), 
or a biomimetic template for bone deposition following 
osteoblast differentiation by another means (LeGeros, 
2008). However, surface reactivity and carbonate 
apatite precipitation may only be a permissive factor in 
osteoinduction, not an osteogenic trigger. Taking the case 
of osteoinductive titanium as an example, Fujibayashi et al. 
(2004) reported that although both titanium mesh cylinders 
and porous blocks formed an apatite layer in simulated 
body fluid in vitro after thermochemical treatment, only the 
porous blocks induced ectopic bone formation – potentially 
due to more complex surface topography (Fujibayashi 
et al., 2004). Because surface reactivity and physical 
topography can both influence osteoblast differentiation but 
are linked to surface architecture, it is currently unknown 
which, if either, material property plays a prevailing role 
in osteoinduction (Curran et al., 2006; Habibovic et al., 
2006a; Vlacic-Zischke et al., 2011; Zhao et al., 2007).
 Alternatively, osteoinduction may depend on (pre-)
osteoclast activity for osteogenic signals rather than 
intrinsic physicochemical signals originating from the 
material itself (Baslé et al., 1993; Gauthier et al., 2005; 
Malard et al., 1999). In support of this theory, it has been 
reported that osteoclastogenesis precedes osteoinduction 
by microstructured TCP by several weeks (Akiyama et 
al., 2011; Kondo et al., 2006), and osteoclast depletion 
limits (Ripamonti et al., 2010) or completely blocks de 
novo bone formation by osteoinductive CaPs (Davison 
et al., 2014a). Recently, we reported a clear link between 
TCP microstructure, osteoclastogenesis, and subsequent 
de novo bone formation (Davison et al., 2014a; Davison 
et al., 2014b). However, (pre-)osteoclast differentiation 
and activity is influenced by multiple substrate parameters 
including surface nano-/microroughness (Makihira et al., 
2007; Webster et al., 2001), solubility (Benahmed et al., 
1996; Yamada et al., 1997), and the accompanied release 
of nano-/microparticulate (Fellah et al., 2007; Velard et 
al., 2013), so it is currently unknown if this link also holds 
true for less resorbable materials like BCP or titanium.
 Given the present knowledge, we hypothesised 
that surface structure is the preeminent material factor 
responsible for the formation of both osteoclast-like 
cells and de novo bone. To evaluate this, two BCPs with 
different surface structure were prepared in the form 
of planar, non-macroporous discs, thus eliminating the 
effects of interconnected macropores, concavities, or 
interparticle space. To evaluate whether the surface 
chemistry contributes to osteoinductivity, BCP was 
also surface coated with titanium. Disc constructs were 
implanted in the dorsal muscle of dogs, the classical model 
for evaluating osteoinduction, and the formation of de 
novo bone and multinucleated osteoclast-like cells was 
analysed by histology. The effects of surface structure and 
chemistry on osteoclastogenesis were further evaluated 
in vitro using the RAW264.7 pre-osteoclast cell line, as 
previously described (Davison et al., 2014b). Osteoclast 
differentiation, survival and morphology were measured 
and quantitatively compared using several biochemical, 
histological and morphological techniques.
Materials and Methods
Preparation and characterisation of BCP
BCP powder composed of 80 % HA/20 % β-TCP was 
prepared by wet precipitation as described elsewhere (Yuan 
et al., 2002). The powder was foamed with diluted H2O2 
(0.1 %) (Merck, Schiphol-Rijk, Netherlands) at 60 °C to 
produce microporous green bodies and then dried. The 
dry green bodies were subsequently sintered at 1150 °C or 
1300 °C for 8 h to achieve surface micro-grains and pores 
(BCP1150) or larger fused grains and few micropores 
(BCP1300). Ceramic discs (Ø 9 × 1 mm) were machined 
from the ceramic bodies using a lathe and a diamond saw 
microtome (Leica SP1600). Discs were ultrasonically 
cleaned in successive baths of acetone, ethanol and 
deionised water for 15 min, and then dried at 60 °C.
 To obtain a different surface chemistry while 
preserving the surface microstructure, BCP1150 discs 
were sputter coated with titanium (BCP1150Ti) using a 
radiofrequency magnetron unit (Edwards ESM 100) as 
previously described (Wolke et al., 1998). Both sides of 
the discs were coated for 15 min at 200 W, resulting in a 
visually complete layer of titanium roughly 50 nm thick. 
The elemental composition and distribution of the titanium 
coating was verified using electron dispersive spectroscopy 
(EDS), as previously described (Bongio et al., 2013). 
Briefly, samples were affixed to metal stubs and scanned by 
a scanning electron microscope (Philips XL30) equipped 
with an energy dispersive spectrometer (EDAX, Ametek). 
The distribution of elements of interest (Ca, P and Ti) was 
analysed and visually displayed. The associated error for 
all the EDS analyses was calculated to be less than 10 %.
 Surface structure of the materials was characterised by 
scanning electron microscopy (SEM) (JEOL JSM-5600) 
after sputter coating with gold for 90 s (JEOL JFC 1300). 
Surface grain and pore size were quantified in scanning 
electron micrographs (magnification: 5000×, n = 3 random 
locations) by measuring the vertical distance across the 
features (n > 50) in Image J software (NIH, Bethesda, MD, 
USA).
 Crystal chemistry of the materials was analysed by 
X-ray diffraction (Rigaku Miniflex II) scanning the range 
2θ = 25-45° (step size = 0.01°, rate = 1° min-1) as previously 
described (Davison et al., 2014b). The surface reactivity of 
the discs was analysed in simulated physiologic solution 
(SPS) (50 mM HEPES, 140 mM NaCl, and 0.4 mM NaN3 
for sterility; all from Sigma Aldrich, Saint Louis, MO, 
USA) at pH 3 and pH 7. Discs (n = 3) were incubated in 
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SPS (8 mL) in a tissue culture multiwell plate incubated 
at 37 °C, 5 % CO2 for 7 d with gentle shaking. The 
solution was sampled and refreshed with the same amount 
(100 μL) after 10 min, 1, 2, 4 h, 1, 4 and 7 d. Calcium 
and phosphate released into the solution were quantified 
using QuantiChrom (BioAssay System, Hayward, CA, 
USA) and PhoshoWorks (AAT BioQuest, Sunnyvale, CA, 
USA) colorimetric assay kits, respectively, following the 
manufacturers’ instructions. Absorbance was detected 
using a Zenyth 3100 multimode spectrophotometer.
In vivo study of osteoinduction by BCP constructs
Implantation of sandwich constructs
BCP constructs were implanted in the dorsal muscle of dogs 
to test their capacity to form ectopic bone. BCP constructs 
were made by gluing (Cyanoacrylate “Superglue”, Pertex, 
Cornwall, UK) two discs together with two strips of nylon 
wire (~ Ø0.7 mm) in between to create a central gap (Fig. 
3A). “Sandwich” shaped constructs were sterilised by 
gamma irradiation (> 25 kGy) prior to implantation.
 All surgery was conducted at the Animal Centre of 
Sichuan University in conformance with the institutional 
animal ethics committee’s guidelines. Sterile BCP 
constructs were implanted in the dorsal muscle of healthy 
male mongrel dogs (n = 5 dogs, 1-4 years, 10-15 kg) for 
12 weeks. Animals were first given general anaesthesia by 
abdominal injection of sodium pentobarbital (30 mg kg−1 
body weight) and constructs were implanted into paraspinal 
muscle pockets created by scalpel incision and blunt 
dissection. One construct of each material was implanted 
in each dog resulting in 3 constructs implanted per animal. 
Skin incisions were closed layer by layer with non-
resorbable sutures for identification at harvest. Following 
surgery, the animals were given daily intramuscular 
injections of buprenorphine (0.1 mg per animal) for 2 d and 
penicillin (40 mg kg-1) for 3 d to relieve pain and prevent 
infection. Animals were allowed to undertake full activity 
and received a normal diet immediately after surgery.
Sample harvest and histological processing
At the end of 12 weeks, the animals were euthanised by 
abdominal injection of sodium pentobarbital (60 mg kg-1) 
and samples were immediately harvested and fixed in cold 
phosphate-buffered formalin solution, dehydrated in graded 
ethanol series, and embedded in methyl methacrylate 
(MMA) (LTI, Bilthoven, Netherlands) at room temperature. 
Histological sections (~ 30 μm) of the undecalcified 
samples were made using a Leica SP1600 microtome and 
stained en bloc with 1 % methylene blue and 0.3 % basic 
fuchsin solutions for histological analysis.
 Stained histological sections were scanned using a 
Dimage Scan Elite 5400II slide scanner (Konica Minolta) 
for gross evaluation. Bone formation was analysed at 20× 
magnification using a light microscope (Nikon Eclipse 
E200). More than 10 sections per sample spanning more 
than half the construct were analysed for de novo bone 
formation by 2 investigators (ND and JS), and the number 
of samples positive for bone formation per the total number 
of samples implanted (i.e., bone incidence rate) was 
recorded.
In vitro studies
Culture of RAW264.7 osteoclasts and C2C12 myoblasts 
on BCP discs
To model osteoclastogenesis in vitro, murine RAW264.7 
macrophages (ECACC, Salisbury, UK) were cultured on 
the surface of BCP discs for up to 5 d in the presence of 
osteoclast differentiation factor RANKL (receptor activator 
for NF-κB ligand) as described previously (Collin-Osdoby 
et al., 2003). RAW264.7 cells were first expanded in tissue 
culture flasks with basic medium composed of alpha 
MEM (Lonza, Breda, Netherlands), supplemented with 
10 % HyClone FetalClone I serum (Thermo Scientific, 
Waltham, MA, USA) and 1 % penicillin-streptomycin (Life 
Technologies, Merelbeke, Belgium). At ~ 75 % confluence, 
cells were scraped loose from the tissue culture flasks, 
resuspended in basic medium supplemented with RANKL 
(40 ng mL-1, Peprotech, London, UK), and seeded on BCP 
discs (2 × 104 cells cm-2). All discs were heat sterilised in a 
dry chamber at 200 °C for 2 h prior to cell culture.
 RAW264.7 cells were cultured for 5 d with medium 
refreshment (basic medium + RANKL) after 1 d. In our 
previous experience with this culture model (Davison 
et al., 2014b), cells begin to fuse and differentiate into 
osteoclasts by day 3, continue fusing through day 4-5, 
and undergo apoptosis by day 6-7 (Collin-Osdoby et al., 
2003; Takahashi et al., 2007). Therefore, biochemical 
assays focused on day 3-5 as the relevant period of 
osteoclastogenesis. Osteoclast culture experiments were 
repeated to confirm the results of the various assays 
described below.
 C2C12 myoblasts were cultured on BCP discs to study 
the effects material properties on muscle cells. C2C12 cells 
were similarly expanded in basic medium, trypsinised at 
confluence, and cultured on BCP discs (seeding density 
= 2 × 104 cells cm-2) for 5 d. All cells were cultured in a 
humidified incubator maintained at 37 °C and 5 % CO2.
Cell viability, proliferation, and DNA content
The AlamarBlue (AB) fluorescent assay (Life Technologies) 
was used to measure cell viability and proliferation 
(Nakayama et al., 1997) on BCP. AB measures the 
reductive activity inside living cells, and is commonly used 
in the literature as a more sensitive alternative to formazan-
based cell viability assays such as MTT and XTT (Ahmed 
et al., 1994; Gloeckner et al., 2001). At various culture 
time points, cells were incubated with culture medium 
containing 5 % AB reagent for 2 h in culture conditions 
and then media samples were collected in a 96-well plate 
for fluorescent detection (excitation = 530 nm, emission 
= 590 nm) using a Zenyth Multimode plate reader. Cell 
proliferation can be measured by assaying cell viability 
over time (Nakayama et al., 1997). For this assay, the same 
procedure was followed except that AB-containing culture 
medium was removed and refreshed with normal culture 
medium, and then continuously cultured until the next time 
point. For viability and proliferation assays, n = 3 culture 
replicates were measured.
 DNA content was measured in the cell lysate using a 
CyQuant DNA detection kit (Life Technologies). After 3, 
4 and 5 d culture on discs, adherent cells were rinsed in 
phosphate-buffered saline (PBS) and then freeze-thawed 
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in CyQuant cell lysis buffer, as recommended by the 
manufacturer. Cell lysate was thoroughly homogenised 
and sampled from n = 3 replicate discs for measurement 
using the kit. A Zenyth 3100 Multimode plate reader was 
used to detect the fluorescent signal of the assay.
Tartrate resistant acid phosphatase (TRAP) activity
Tartrate resistant acid phosphatase (TRAP) activity, an 
enzyme marker of osteoclast differentiation (Halleen et 
al., 2001), was measured in RAW264.7 cells cultured on 
discs after 3, 4 and 5 d by both biochemical activity and 
cytochemical staining. TRAP activity in the cell lysate from 
n = 3 culture replicates was quantified by conversion of 
p-nitrophenylphosphate to p-nitrophenol (pNP) in sodium 
acetate buffer (pH 5.8) containing potassium sodium 
tartrate (10 mM), as reported by Ljusberg et al. (1999). 
Cell lysate was obtained by first rinsing disc-adherent 
cells with PBS and then freeze-thawing in cell lysis buffer 
(0.1 M sodium acetate, 0.1 % Triton X-100, pH 5.8). All 
reagents were purchased from Sigma Aldrich. Optical 
absorbance of the assay reaction was measured using a 
Zenyth multimode spectrophotometer. Absorbance was 
converted to mM pNP using a standard curve of pNP 
(Sigma Aldrich) and normalised to viable cell signal from 
AlamarBlue. TRAP was also visualised on n = 2 disc 
replicates using a commercial staining kit (Leukocyte Acid 
Phosphatase Kit, Sigma Aldrich). Prior to staining, cells 
were briefly rinsed in PBS and fixed in acetone methanol 
solution as per the manufacturer’s instructions. Images 
were captured using a Nikon SMZ800 stereomicroscope 
equipped with a Nikon camera.
SEM of osteoclast morphology
Osteoclast morphology was analysed by SEM. Cells 
cultured on discs (n = 2) were fixed in 2.5 % glutaraldehyde, 
dehydrated in a graded ethanol series, and finally dried in 
hexamethyldisilazane (HMDS; Alfa Aesar, Karlsruhe, 
Germany). Dehydrated cells were then sputter coated 
with gold for enhanced imaging resolution. Osteoclast 
size was quantified in scanning electron micrographs 
(400× magnification), by calculating the mean surface 
area of cells at 3 random locations of replicate discs 
(n = 2) using automated threshold, edge detection, and 
particle analysis functions in ImageJ software (NIH), as 
previously described (Davison et al., 2014b). Only cells 
> 400 μm2 were included in the analysis to safely exclude 
mononuclear cells.
Statistical analysis
Statistical comparisons were performed using One-way 
ANOVA and Tukey’s post hoc tests; p values < 0.05 
were considered significant. All statistical analyses were 
conducted in GraphPad Prism 6.0.
Results
BCP characterisation
BCP1150 and BCP1300 with different surface 
microstructures were prepared by changing the sintering 
temperatures, as shown by SEM (Fig. 1A). Quantitatively, 
BCP1150 contained grains and pores sized ≤ 1 μm in 
diameter but BCP1300 contained larger, fused grains 
Fig. 1. Surface characterisation of BCP. Scanning electron micrographs show the difference in surface microstructure 
between BCP1150 and BCP1300 and the similarity between BCP1150 and BCP1150Ti with titanium coating 
(scale = 10 μm) (A). Surface grain and pore size ≤ 1 μm of BCP1150 were unchanged by titanium coating; however, 
grains and pores of BCP1300 were significantly larger (B). **** p < 0.0001.
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(~ 3 μm) and larger but fewer micropores (~ 2 μm) (Fig. 
1B)). Because no macropore porogens were introduced 
during synthesis, neither material contained macropores 
or substantial concavities. Sputter coating BCP1150 with 
titanium (BCP1150Ti) did not visibly change the surface 
microstructure by SEM (Fig. 1A) or the size of the surface 
grains and pores (Fig. 1B) versus BCP1150.
 The crystal chemistry of the materials was confirmed 
by X-ray diffraction (XRD) to be BCP containing 80-
85 % HA and 15-20 % TCP (Fig. 2A). Coating BCP1150 
with titanium did not substantially alter the XRD spectra. 
The surface reactivity of the materials was analysed by 
measuring calcium and phosphate ion release in simulated 
physiologic solution (SPS) at pH 7 and pH 3 (Fig. 2B). At 
neutral pH, all three materials released similar amounts of 
ions over time, but at acidic pH, ion release from BCP1150 
and BCP1150Ti was higher than BCP1300, resulting from 
the increased surface area of the microstructure. There was 
no change in ion release by BCP1150 with or without the 
titanium coating showing that the coating did not change 
the chemical reactivity of the material (Fig. 2B).
 Sputter coating BCP1150 with titanium resulted in 
a visually homogenous layer on all sides of the discs 
(Fig. 3A). The titanium layer was analysed by EDS, 
which showed the homogeneously distributed titanium 
coating on the surface (Fig. 3B) that remained on the 
surface after implantation (Fig. 4). In summary, sputter 
coating BCP1150 with titanium resulted in a material 
with equivalent microstructure and chemical reactivity but 
different surface chemistry.
In vivo results
BCP sandwich constructs were implanted into the dorsal 
muscle of dogs for 12 weeks to study the effects of surface 
microstructure and chemistry on osteoinduction. A gap 
between the BCP discs was created using nylon wire 
spacers to allow tissue in-growth and bone formation (Fig. 
5A). However, soft tissue formation in the space between 
the discs and around the nylon wires tended to be weak 
for all materials compared to tissue formation on the outer 
edges of the constructs (Fig. 5B).
 The incidence of de novo bone formation was quantified 
by thorough analysis of histological sections. De novo bone 
formation was observed in 4 out of 5 BCP1150 constructs, 
3 out of 5 BCP1150Ti constructs, and 0 out of 5 BCP1300 
constructs (Table 1). For BCP1150 and BCP1150Ti, bone 
was predominantly formed on the outer surfaces of the 
constructs (Fig. 6A) rather than on the inner surfaces of the 
central gap. Although stretches of bone were not thicker 
Fig. 2. Chemical characterisation 
of BCP. The XRD spectra were 
equivalent for all three BCP 
materials (A). Chemical reactivity 
in simulated physiologic solution 
(SPS) showed that ion release of 
all three materials was equivalent 
at pH 7, but slightly faster for 
BCP1150 with and without 
titanium coating than BCP1300 
at pH 3 (B). Data represents the 
mean ± S.D. of n = 3 replicate 
discs, p < 0.0001.
Table 1. Incidence rate of specimens containing 
de novo bone formation
BCP1150 BCP1150Ti BCP1300
4/5 3/5 0/5
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Fig. 3. Elemental analysis of BCP1150Ti by electron dispersive spectroscopy (EDS). (A) Overview images of BCP1150 
and BCP1150Ti show that discs were appreciably devoid of concavities or macropores and that titanium coating 
uniformly covered the disc surfaces. (B) Elemental diffraction spectroscopy (EDS) analysis (2,000× magnification) 
shows titanium (Ti) on the surface of BCP1150Ti (left column) was evenly distributed and porous similar to the 
underlying substratum composed of calcium (Ca) and phosphorus (P). In comparison, BCP1150 (right column) 
depicted only background noise. Scale = 10 μm.
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Fig. 4. Elemental analysis of BCP1150Ti explant. After 12 weeks intramuscular implantation, a thin layer of titanium 
was still intact on the edge of the BCP115Ti construct cross-section. Scale = 50 μm.
Fig .  5 .  I n t r amuscu l a r 
i m p l a n t a t i o n  o f  B C P 
sandwich constructs. BCP 
sandwich constructs were 
made by gluing together two 
BCP discs with a central gap 
in between them using nylon 
wire spacers (A). Constructs 
were implanted in the dorsal 
muscle of dogs for 12 weeks 
and histological sections 
were stained with methylene 
blue and basic fuchsin (B). 
Overview images of cross-
sections taken through the 
middle of explants show soft 
tissue (pink, purple, blue) 
formation around the BCP 
constructs (brown, black) 
with limited tissue infiltration 
in the gap between the discs. 
Tissue often delaminated 
f r o m  t h e  s u r f a c e  o f 
BCP1300 constructs (black 
arrows), indicating weak 
tissue bonding. Note: few 
macropores or concavities 
were present in the discs. B, 
scale = 1 mm.
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than ~ 50 μm and generally spanned less than several 
hundred μm long, cuboidal osteoblasts were seen forming 
new bone and osteocytes were present in bone lacunae (Fig. 
6A). Bone area was not quantified by histomorphometry 
due to the small amounts present.
 Multinucleated osteoclast-like cells extensively 
covered the surface of BCP1150, but were smaller and less 
organised on BCP1150Ti (Fig. 6B). For both materials, 
osteoclast-like cells adhered to the material adjacent 
to de novo formed bone. In contrast to BCP1150, with 
and without a titanium coating, BCP1300 was largely 
encapsulated by fibrous tissue and contained scarce 
multinucleated osteoclast-like cells (Fig. 6B).
In vitro results
Cell viability and proliferation
To further investigate the effects of BCP surface structure 
and chemistry on osteoclast-like cell formation, RAW264.7 
macrophages were cultured on BCP discs and differentiated 
into osteoclast-like cells using RANKL. At day 3, 4 and 5, 
Fig. 6. Histology of intramuscularly implanted BCP sandwich constructs. (A) At 10× magnification of the outer 
surface of the constructs (top row), a thin layer of ectopic bone (red/pink) was evident on BCP1150 and BCP1150Ti, 
but only fibrous tissue (blue/purple) was present on BCP1300. Scale = 100 μm. At 40× magnification (bottom row), 
osteocytes (white arrowheads) resided in characteristic bone (asterisk) lacunae on the surface of both BCP1150 and 
BCP1150Ti. Flattened osteoblasts (black arrowheads) surrounded by condensing matrix flanked the ectopic bone 
formed on BCP1150. Scale = 25 μm. (B) Multinucleated cells (black arrows) formed on BCP1150 were larger and 
more densely organised than on BCP1150Ti, while no discernible multinucleated cells were present on the surface of 
BCP1300 (left column). Scale = 25 μm. Multinucleated osteoclast-like cells bordered ectopic bone on BCP1150 and 
BCP1150Ti; however, these cells appeared smaller and less fused on BCP1150Ti than on BCP1150 (right column). 
The intact titanium layer on BCP1150Ti was evident throughout the micrographs (thin black strip on the construct 
surface). Scale = 25 μm.
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DNA content from cells cultured on BCP1150 was ~ 3-5 
times greater than on BCP1300 (day 3: p < 0.0001; day 
4: p = 0.0001; day 5: p = 0.004) (Fig. 7A). DNA content 
from cells cultured on BCP1150Ti was also significantly 
greater than on BCP1300 (p < 0.01), at levels similar to 
BCP1150 at day 4 and 5 (Fig. 7A). These data indicated 
that the difference in titanium coating had little effect on 
cell growth; however, the difference in microstructure had 
a pronounced effect. After 5 d of culture, cell viability 
was ~ 2× higher on both BCP1150 and BCP1150Ti than 
on BCP1300 (both p < 0.0001) (Fig. 7B). Further, cell 
viability was higher for BCP1150Ti than for BCP1150 
(p = 0.002) (Fig. 7B).
 RAW264.7 cell proliferation was analysed on BCP1150 
and BCP1300 by measuring cell viability over time 
normalised to the viability at the time of seeding (d0) 
(Fig. 7C). BCP1150Ti was not included in this analysis, 
focusing only on the effects of surface structure, not 
surface chemistry. At day 1, cell viability was similar 
on the materials suggesting that initial cell attachment 
was equivalent. By day 3, RAW264.7 cell proliferation 
was significantly greater for BCP1150, resulting in ~ 2× 
greater viability than on BCP1300 (p = 0.001). The same 
difference in cell viability was maintained through day 4 
(p = 0.004) and day 5 (p = 0.005), indicating that BCP1150 
stimulated significantly more proliferation of RAW264.7 
cells than BCP1300 over the entire culture period. In fact, 
RAW264.7 cells cultured on BCP1300 did not proliferate 
between 1 and 5 d in culture (Fig. 7C). To evaluate if 
interactions with BCP1300 inhibited the proliferation of 
other cell types, C2C12 myoblasts were also cultured on 
the materials, but in contrast, these cells proliferated in 
typical logarithmic fashion on BCP1300 and to a greater 
extent than on BCP1150 by day 4 and 5 (p = 0.003 and 
p = 0.001, respectively) (Fig. 7D).
 In sum, BCP1150 promoted significantly higher cell 
growth and viability of RAW264.7 (pre-)osteoclasts than 
BCP1300 in a process that was not adversely affected by 
Fig. 7. Cell viability and proliferation on BCP in vitro. RAW264.7 cells were cultured on BCP discs in the presence 
of RANKL for 5 d to stimulate osteoclast formation. DNA content in the lysate from cells cultured on BCP1150 was 
significantly higher than on BCP1300 at day 3, 4 and 5. DNA content was different between BCP1150 and BCP1150Ti 
at day 3 and 4; however, they were equivalent by day 5 (A). At day 5, osteoclast viability was also significantly 
higher on BCP1150 and BCP1150Ti than on BCP1300, as measured by AlamarBlue (AB) metabolic indicator (AB 
RFU = AB relative fluorescent units) (B). Comparing the effects of only surface microstructure, RAW264.7 cells 
were again cultured in the presence of RANKL on BCP1150 and BCP1300 and cell viability was measured over time 
indicating cell proliferation. After 1 day, viability was equivalent between BCP1150 and BCP1300, but by days 3, 4 
and 5 cells had proliferated on BCP1150 but not on BCP1300 (C). In contrast, C2C12 myoblasts proliferated more 
on BCP1300 than on BCP1150 (D). Data represent the mean ± S.D. of n = 3 replicate discs. * p < 0.05, ** p < 0.01, 
*** p < 0.001, **** p < 0.0001.
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titanium coating; however, this response was not universal 
to other cell types such as C2C12 myoblasts.
TRAP activity
TRAP enzyme activity in the RAW264.7 cells was assayed 
both biochemically in the cell lysate and cytochemically 
by staining. Biochemical TRAP activity in the lysate of 
cells cultured on BCP1150 was significantly higher than 
that of BCP1300 at day 3 (~ 4×, p < 0.0001), day 4 (~ 3×, 
p < 0.0001) and day 5 (~ 2×, p = 0.008) (Fig. 8A). Cells 
cultured on BCP1150Ti also expressed significantly more 
TRAP activity than BCP1300 at day 3 (~ 2×, p = 0.023) 
and day 4 (~ 2.5×, p = 0.002), although at day 5 there was 
no statistical difference (p = 0.194). Cellular TRAP activity 
was different between BCP1150 and BCP1150Ti at day 3 
(~ 1.8×, p = 0.004); however, by day 4 and 5 there was no 
statistical difference (p = 0.144 and 0.102, respectively) 
(Fig. 8A).
 To visually confirm the biochemical results, cells 
were stained for TRAP at the same time points (Fig. 8B). 
Fig. 8. Tartrate resistant acid phosphatase (TRAP) activity of RAW264.7 osteoclasts cultured on BCP. Biochemical 
TRAP activity in the cell lysate was significantly higher on BCP1150 than BCP1300 throughout the culture period, 
as well as BCP1150Ti at day 3 (A). By cytochemical staining, osteoclasts formed on BCP1150 are consistently 
larger, denser, and more intensely stained than on BCP1300, in agreement with the biochemical assay (overview 
scale = 2 mm; detail scale = 500 μm) (B). Visualisation of TRAP staining was not possible on BCP1150Ti discs, due 
to their dark colour. Biochemical TRAP activity (mM pNP normalised to viable cells, AB RFU) represents the mean 
± S.D. of n = 3 replicate discs. * p < 0.05, ** p < 0.01, **** p < 0.0001.
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Visualisation of TRAP staining on BCP1150Ti was not 
possible because of the dark colour of the coating. A clear 
difference in osteoclast fusion and TRAP activity between 
BCP1150 and BCP1300 was observed (Fig. 8B): cells 
were substantially larger and more intensely stained on 
BCP1150 at all time points. On BCP1150, numerous cell-
cell junctions were observed between densely distributed 
cells; in contrast, on BCP1300, cell junctions were sparse 
likely owing to less cells present (Fig. 8B), in confirmation 
of the cell viability and DNA assays (Fig. 7).
Osteoclast morphology and size
Osteoclast morphology and size were analysed by SEM 
at day 5, corresponding with the peak of TRAP activity 
and cell fusion visualised by TRAP staining (Fig. 9). On 
BCP1150, fused cells were massive (~ 4,000 μm2) and 
tightly attached to the BCP surface in an extensive cell 
network. Single cells were generally found in clusters, with 
partially fused cell membranes. In contrast, fused cells on 
BCP1150Ti were ~ 75 % smaller (~ 1,000 μm2, p = 0.002) 
and appeared rounder and less spread out on the surface. On 
BCP1300, fused cells were also smaller than on BCP1150 
(~ 1,500 μm2, p = 0.008), and often appeared to be apoptotic 
or necrotic with deteriorating cell membranes. Fewer cells 
were present on BCP1300 than BCP1150 and BCP1150Ti, 
in agreement with the cell viability and DNA assays.
Discussion
In the present results, BCP and titanium-coated BCP 
with small surface microstructural dimensions (~ 1 μm) 
promoted osteoclast-like cell formation along with de 
novo bone formation, while larger surface architecture 
(~ 2-4 μm) inhibited these effects. Moreover, macro-scale 
features such as concavities, macropores, or interparticle 
space were unnecessary to stimulate this response. These 
in vivo observations were further investigated in vitro 
using a previously described osteoclastogenesis model 
(Davison et al., 2014b). Notably, osteoclast survival 
and differentiation were significantly promoted by 
the osteoinductive surface structure of BCP1150 and 
BCP1150Ti versus the non-inductive surface structure of 
BCP1300. Pre-osteoclast proliferation was also stunted by 
BCP1300 versus BCP1150; however, C2C12 myoblasts 
proliferated strongly on BCP1300 versus BCP1150, 
Fig. 9. Scanning electron microscopy (SEM) of osteoclasts formed on BCP. SEM micrographs captured at day 5 show 
massive networks of fused osteoclasts on BCP1150 (large dark cells), whereas cells were significantly smaller and 
less fused on BCP1150Ti and BCP1300 (150× scale = 100 μm; 400× scale = 50 μm). Osteoclast size data represents 
the mean ± S.D. of n = 2 replicate discs. ** p < 0.01.
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illustrating that BCP1300 was not universally detrimental 
to cell proliferation. These in vitro results may also explain 
why few multinucleated cells but abundant soft tissue was 
present on this surface in vivo. Regarding osteoclast fusion 
and size, BCP1150 stimulated the formation of large, fused 
osteoclasts that were ~ 2-4 times larger than those formed 
on either BCP1150Ti or BCP1300 in vitro. In this way, 
surface microstructural dimensions of ~ 1 μm promoted 
(pre-)osteoclast proliferation, differentiation, and survival 
versus larger surface structure, while titanium surface 
chemistry appeared to limit osteoclast fusion.
 At the onset of the present study, it was unclear whether 
planar, macroscopically flat implants could induce bone 
formation, based on a lack of direct investigation in the 
literature (Barradas et al., 2011). Bone formed on the 
outside surface of the microstructured constructs, not 
only between the discs; thus, the crucial role of surface 
microstructure on osteoinduction was more clearly isolated 
and interparticle space was shown to be dispensable. Still, 
the amount of ectopic bone formed in the present study 
was small in comparison to the ectopic bone formed by a 
similar microstructured BCP with macroporous structure, 
as previously reported (Habibovic et al., 2006b; Yuan 
et al., 2010). So, macrostructural features may enhance 
bone deposition after it has already been triggered by 
osteoinductive microstructure.
 Ectopic bone also formed on the titanium surface 
of BCP1150Ti indicating that surface chemistry is a 
flexible parameter in the osteoinductive performance of 
microstructured materials. Rather than being fully sealed, 
the line-of-sight sputter deposition of titanium on BCP1150 
preserved the chemical reactivity of the BCP substrate and 
was still intact after implantation. Whereas BCP1150Ti 
possessed small surface microarchitecture and similar 
dissolution profile of the underlying BCP1150 substrate, 
other osteoinductive titanium materials described in the 
literature possess nano-/microarchitecture (Fujibayashi 
et al., 2004; Fukuda et al., 2011), and being fully made 
up of titanium are incapable of releasing calcium or 
phosphate ions into solution. In a preliminary step toward 
the development of osteoinductive titanium, Kokubo 
(1996) showed that alkali followed by thermal treatment 
of pure titanium resulted in a stabilised microporous 
surface structure that could form a carbonate apatite layer 
in vitro and in vivo, and even bond directly to native 
bone (Kokubo, 1996; Kokubo et al., 1996). Tuning this 
alkali thermal treatment (10 M NaOH to 5 M NaOH) 
later resulted in a different nano-/microrough surface and 
the induction of de novo bone (Fujibayashi et al., 2004; 
Fukuda et al., 2011). However, in these same studies it 
was found that apatite formation alone was not sufficient 
to induce ectopic bone formation, despite the positive 
impact on osseointegration. Similarly, it is known that 
BCP readily forms a carbonate apatite layer in body fluid 
(Daculsi et al., 1989; Daculsi et al., 1990), which we also 
confirmed for BCP1150 and BCP1300 in simulated body 
fluid (data not shown); however, only BCP1150 – and now 
BCP1150Ti with equivalent microstructure – can induce 
ectopic bone formation. In agreement with the conclusion 
of Fujibayashi et al. (2004), we propose that these 
differences hinge on microarchitecture (i.e., topography) 
although apatite formation is likely a prerequisite for 
osteoinduction to take place because of its importance 
for bone-bonding. Considering that collagen fibres also 
infiltrate a microporous, osteoinductive surface before 
de novo bone formation (Kondo et al., 2006), apatite 
formation and microarchitecture may synergise to provide 
a biomimetic template for both phases of bone tissue.
 Because BCP1150, BCP1150Ti and BCP1300 all 
shared similar Ca2+ and Pi release profiles in vitro, the 
differences in bone formation are difficult to explain in 
terms of intrinsic differences in surface reactivity or Ca2+/Pi 
signalling. However, this in vitro characterisation is limited 
in light of the physico-chemical complexity of body fluid 
in vivo, including supersaturated Ca2+/Pi levels as well as 
blood serum (Garnett and Dieppe, 1990). Other theories 
on osteoinduction speculate that material degradation 
by osteoclast resorption or macrophage phagocytosis 
may independently speed the dissolution/precipitation 
of a bioactive carbonate apatite layer (LeGeros, 1993), 
establish an instructive geometric template for de novo 
bone formation in resorption lacunae along with increased 
local Ca2+ concentrations (Klar et al., 2013; Ripamonti et 
al., 2008; Wilkinson et al., 2011), or liberate crystalline 
nano-/microparticulate and a subsequent osteogenic 
cytokine cascade (Gauthier et al., 1999; Malard et al., 1999; 
Velard et al., 2013). However, in the present study neither 
characteristic osteoclast resorption lacunae nor degraded 
BCP particulate were apparent in the histology.
 Alternatively, decades of research have shown that 
surface topography can directly stimulate bone cell 
differentiation and function on various material substrates, 
including polymers (Fu et al., 2010; Watari et al., 2012; 
Wilkinson et al., 2011; You et al., 2010), titanium 
(Brunette, 1988; Gittens et al., 2011; McNamara et al., 
2011), ceramics (Webster, 2000; Zhang et al., 2014), and 
tissue (Gray et al., 1996). Topographical control of cell 
fate is a complex phenomenon that can occur through focal 
adhesion clustering and downstream focal adhesion kinase 
(FAK) signalling (McNamara et al., 2010). This cascade is 
initiated when cell surface integrins bind matrix proteins 
adsorbed to the substrate (Chou et al., 1995; Stevens and 
George, 2005), so protein adsorption from the body fluid 
may play a crucial role in the differences in cell-surface 
interactions observed in the present study. Indeed, our 
previous experiments showed that microstructured 
BCP1150 adsorbs more proteins than denser BCP1300 
(Yuan et al., 2010).
 With respect to the role of osteoclasts in osteoinduction, 
the present study further substantiates a link between 
microstructure, osteoclastogenesis, and eventual de novo 
bone formation. We previously reported similar findings 
using TCP with two different surface structures, analogous 
to BCP1150 and BCP1300 investigated in the present study 
(Davison et al., 2014b; Zhang et al., 2014). TCP possessing 
surface microstructural dimensions ≤ 1 μm (TCPs) was 
extensively colonised by multinucleated osteoclast-like 
cells adjacent to substantial amounts of ectopic bone in 
the muscle tissue of dogs after 12 weeks. In contrast, TCP 
with larger surface structural dimensions (~ 2-4 μm, TCPb) 
contained few multinucleated cells and formed no ectopic 
bone. Moreover, TCPs significantly promoted osteoclast 
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differentiation and fusion versus TCPb using the same in 
vitro osteoclastogenesis model applied in the present study 
(Davison et al., 2014b). Taking these previous and current 
results together, it can be concluded that for both BCP 
and TCP – representing the most frequently investigated 
osteoinductive materials in the literature (Barradas et al., 
2011) – surface microstructural dimensions of ~ 1 μm 
robustly promoted the formation of osteoclast-like cells 
concurrent with de novo bone formation. These results 
add to the growing consensus that osteoclast formation 
is prerequisite for osteoinduction (Davison et al., 2014a; 
Klar et al., 2013; Kondo et al., 2006; Le Nihouannen et 
al., 2005); however, it is still unknown what the exact role 
of osteoclasts is in this process.
 It has also been suggested that CaPs may stimulate 
bone formation by absorbing BMPs (bone morphogenetic 
proteins) endogenously synthesised near the implant 
surface (Klar et al., 2014; Ripamonti et al., 1993) or 
circulating in the blood (de Groot, 1998). However, 
large doses of BMPs are required to stimulate substantial 
amounts of de novo bone formation, likely rendering 
basal levels of BMPs circulating in the blood ineffective 
in achieving this response (van Baardewijk et al., 2013; 
Yuan et al., 2010). Alternatively, BMPs or other osteogenic 
factors may originate from (pre-)osteoclast interactions 
with microstructured surfaces including CaP (Davison et 
al., 2014b) and titanium (Takebe et al., 2003). Elevated 
Ca2+ levels resulting from osteoclast resorption of a 
mineralised substrate can also stimulate BMP expression 
of precursor cells (Barradas et al., 2012; Klar et al., 2013). 
In support of this, osteoclast depletion by bisphosphonate 
treatment attenuated BMP2 expression in osteoinductive 
CaP implants and limited ectopic bone formation (Klar 
et al., 2013), potentially because osteoclasts synthesise 
a variety of BMPs (Garimella et al., 2008). Moreover, 
treatment with noggin, which blocks BMP binding to 
its membrane-bound receptor, also stunted ectopic bone 
formation by an osteoinductive CaP (Klar et al., 2014). 
However, chondrogenesis was not reported in either of 
these studies (Klar et al., 2013; Klar et al., 2014), or in 
a thorough review of osteoinductive materials research 
(Barradas et al., 2011), suggesting that osteoinduction may 
not proceed via a classical BMP-induced endochondral 
pathway. In the broader context of bone metabolism, 
activated (pre-)osteoclasts secrete a variety of other non-
BMP osteogenic factors – e.g., Wnts, S1P, OSM, and 
CTHRC1 – resulting in osteoblast differentiation of local 
precursors (Garimella et al., 2008; Guihard et al., 2012; 
Pederson et al., 2008; Takeshita et al., 2013) through 
intramembranous ossification (Durmus et al., 2006). To 
elucidate the mechanism of osteoinduction, more research 
is needed to discern the distinct molecular pathways 
governing endochondral versus intramembranous 
ossification over the entire time course of ectopic bone 
formation.
 To challenge the theory that osteoclast formation 
promoted by surface (sub)microstructure is instrumental 
for osteoinduction, osteoclastogenesis on other 
osteoinductive materials should be investigated. If, for 
example, microstructured HA and titanium also promoted 
osteoclastogenesis and ectopic bone in contrast to their 
non-microstructured controls, a broader link between 
osteoclast formation and de novo bone formation would 
be further substantiated. Pending deeper biological 
insight, it may be possible to anticipate osteoinductive 
performance based on simplified in vitro osteoclastogenesis 
models. And, if osteoclasts are not only requisite but also 
directive in de novo bone formation through the secretion 
of trophic factors, locally stimulating osteoclastogenesis 
(i.e., controlled release of RANKL) may even render non-
microstructured CaPs osteoinductive.
Conclusion
BCP1150 and titanium-coated BCP1150Ti possessing 
small surface microstructure (~ 1 μm) formed ectopic bone 
adjacent to multinucleated osteoclast-cells in the muscle 
of dogs. Implants were in the form of planar discs so 
macro-scale features such as concavities, macropores and 
interparticle space were unnecessary for this response. In 
contrast, BCP1300 with identical compositional chemistry 
but larger surface architecture (~ 2-4 μm) formed neither 
osteoclast-like cells nor ectopic bone; it was instead 
encapsulated by fibrous tissue. Similar to the in vivo 
results, (pre-)osteoclast proliferation and differentiation 
were significantly promoted by BCP1150 and BCP1150Ti 
versus BCP1300 in vitro; moreover, osteoclasts were larger 
and more fused on BCP1150 versus either BCP1150Ti 
or BCP1300. Together, these in vitro and in vivo results 
indicate that (sub)micron-scale surface architecture is 
the crucial material parameter versus macrostructure or 
surface chemistry in stimulating both osteoclastogenesis 
and ectopic bone formation in a related process.
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